To include your compound in the COVID-19 Resource Center, submit it here.

Quentis debuts with $48M series A

Cancer company Quentis Therapeutics Inc. (New York, N.Y.) raised $48 million on Feb. 27 in a series A round led by

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE